--- title: "RWE, Real-World Evidence | MedTech Terms" description: "Clinical evidence regarding the usage and potential benefits or risks of a device derived from real-world data." lang: en json-ld: | { "@context": "https://schema.org", "@graph": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/real-world-evidence#term", "name": "Real-World Evidence", "alternateName": "RWE", "description": "RWE is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of Real-World Data (RWD), including EHRs, registries, and claims.", "url": "https://medtechterms.com/terms/real-world-evidence", "termCode": "real-world-evidence", "inDefinedTermSet": { "@type": "DefinedTermSet", "name": "MedTech Terms", "url": "https://medtechterms.com/terms" } }, { "@type": "Article", "@id": "https://medtechterms.com/terms/real-world-evidence#article", "headline": "RWE, Real-World Evidence", "description": "Clinical evidence regarding the usage and potential benefits or risks of a device derived from real-world data.", "url": "https://medtechterms.com/terms/real-world-evidence", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://medtechterms.com/terms/real-world-evidence" }, "about": { "@id": "https://medtechterms.com/terms/real-world-evidence#term" }, "articleSection": "Clinical & Trials", "inLanguage": "en", "keywords": "Real-World Evidence, RWE, Clinical & Trials, medical device, MedTech", "author": { "@type": "Person", "name": "Christian Espinosa", "jobTitle": "Founder, Blue Goat Cyber", "url": "https://bluegoatcyber.com" }, "publisher": { "@type": "Organization", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "isPartOf": { "@type": "WebSite", "name": "MedTech Terms", "url": "https://medtechterms.com" }, "datePublished": "2026-05-05", "dateModified": "2026-05-05", "citation": [ { "@type": "CreativeWork", "name": "FDA RWE Framework", "url": "https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence", "publisher": { "@type": "Organization", "name": "FDA" } }, { "@type": "CreativeWork", "name": "ICH Guidelines", "url": "https://www.ich.org/page/ich-guidelines", "publisher": { "@type": "Organization", "name": "ICH" } }, { "@type": "CreativeWork", "name": "ISO 14155 Standard Page", "url": "https://www.iso.org/standard/71690.html", "publisher": { "@type": "Organization", "name": "ISO" } } ], "mentions": [ { "@type": "DefinedTerm", "@id": "https://medtechterms.com/terms/post-market-surveillance#term", "name": "Post-Market Surveillance", "alternateName": "PMS", "url": "https://medtechterms.com/terms/post-market-surveillance" } ] }, { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://medtechterms.com/" }, { "@type": "ListItem", "position": 2, "name": "Terms", "item": "https://medtechterms.com/terms" }, { "@type": "ListItem", "position": 3, "name": "Clinical & Trials", "item": "https://medtechterms.com/terms?cat=Clinical%20%26%20Trials" }, { "@type": "ListItem", "position": 4, "name": "Real-World Evidence", "item": "https://medtechterms.com/terms/real-world-evidence" } ] }, { "@type": "FAQPage", "@id": "https://medtechterms.com/terms/real-world-evidence#faq", "mainEntity": [ { "@type": "Question", "name": "How does RWE differ from traditional clinical trial evidence?", "acceptedAnswer": { "@type": "Answer", "text": "RWE is derived from data collected in routine clinical practice or real-world settings, offering insights into product performance in a broader patient population and under typical usage conditions. Traditional clinical trials, conversely, are typically conducted in highly controlled environments with specific inclusion and exclusion criteria." } }, { "@type": "Question", "name": "Can RWE be used for pre-market submissions?", "acceptedAnswer": { "@type": "Answer", "text": "Yes, regulatory bodies like the FDA accept RWE for pre-market submissions, especially for certain device types or indications, provided the RWD are relevant and reliable. The specific requirements may vary based on the device classification and the type of evidence needed." } }, { "@type": "Question", "name": "What are common sources of Real-World Data (RWD)?", "acceptedAnswer": { "@type": "Answer", "text": "Common RWD sources include electronic health records (EHRs), medical claims data, patient registries, pragmatic clinical trials, and data from wearable devices or mobile health applications." } } ] } ] } --- [ MedTech Terms The authoritative reference ](/) Browse Learn [Latest](/latest) About 1. [Home](/) 2. / 3. [Terms](/terms) 4. / 5. [Clinical & Trials](/terms?cat=Clinical%20%26%20Trials) 6. / 7. Real-World Evidence [All terms](/terms) Clinical & Trials [Quality System](/ecosystems/quality-system)[Clinical Evidence](/ecosystems/clinical-evidence)RWE # Real-World Evidence Clinical evidence regarding the usage and potential benefits or risks of a device derived from real-world data. Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 5, 2026 ## Definition RWE is the clinical evidence about the usage and potential benefits or risks of a medical product derived from analysis of [Real-World Data](/terms/rwd) (RWD), including EHRs, registries, and claims. What the regulation says The FDA issues guidance on the use of Real-World Evidence (RWE) to support regulatory decision-making for medical devices, as outlined in their "Real-World Evidence Guidance for Medical Devices" document. This guidance details considerations for relevance and reliability of [Real-World Data](/terms/rwd) (RWD) sources, aligning with principles for valid scientific evidence. The [EU Medical Device Regulation](/terms/mdr) (EU [MDR](/terms/mdr-reporting)) also acknowledges the value of RWE, particularly for [post-market surveillance](/terms/post-market-surveillance) (PMS) and substantiating clinical benefits and safety in the post-market phase, as described in Annex III, section 1.1(f) regarding clinical evaluation. ## What this means in practice FDA accepts RWE to support regulatory decisions when relevance and reliability are demonstrated. RWE is increasingly important for AI/ML monitoring and [PMS](/terms/post-market-surveillance). ## Examples - A medical device manufacturer uses RWE from a national patient registry to demonstrate the long-term safety and effectiveness of their implanted cardiac device in a diverse patient population. - An AI-powered diagnostic software company utilizes RWE from de-identified electronic health records to support the clinical validity and utility of their algorithm for early disease detection. - A pharmaceutical company submits RWE derived from insurance claims data to support a new indication for an approved drug, showing its effectiveness in a real-world setting outside of a controlled trial. Common pitfalls - • RWE derived from unreliable or biased RWD sources may not be accepted by regulatory authorities, leading to delays or rejection of submissions. - • Failure to adequately document RWD collection methods and RWE analysis plans can undermine the credibility of the evidence. - • Generalizing RWE from one population to another without proper justification is a common pitfall. - • Ignoring potential confounding factors in RWD can lead to inaccurate conclusions about a medical product's performance. - • Using RWE for indications not supported by the data's scope or context will be viewed critically by regulators, such as the FDA. ## Frequently asked questions How does RWE differ from traditional clinical trial evidence? RWE is derived from data collected in routine clinical practice or real-world settings, offering insights into product performance in a broader patient population and under typical usage conditions. Traditional clinical trials, conversely, are typically conducted in highly controlled environments with specific inclusion and exclusion criteria. Can RWE be used for pre-market submissions? What are common sources of Real-World Data (RWD)? ## Cross-references ### See also Closely related context worth reading. - [ Health Technology Assessment(HTA) ](/terms/hta) ## Related terms Grouped by theme ### Editor's picks · Hand-selected related concepts [ Post-Market Post-Market Surveillance(PMS) Activities to monitor device safety and performance after market release. ](/terms/post-market-surveillance) ### Post-Market Mastery · From this learning path [ Quality & Risk Corrective and Preventive Action(CAPA) Systematic process to investigate and resolve quality issues and prevent recurrence. Adjacent lesson ](/terms/capa?from=post-market-mastery)[ Quality & Risk Complaint Handling Process for receiving, evaluating, and responding to device complaints. ](/terms/complaint-handling?from=post-market-mastery)[ Post-Market Field Safety Corrective Action(FSCA) Action taken to reduce a risk of serious deterioration in health associated with a device. ](/terms/fsca?from=post-market-mastery)[ Post-Market Medical Device Recall Removal or correction of a marketed device that violates FDA law. ](/terms/recall?from=post-market-mastery) ### Clinical Trials & Evidence · From this learning path [ Clinical & Trials Clinical Evaluation Report(CER) Documented assessment of clinical data demonstrating EU MDR conformity for a device. Adjacent lesson ](/terms/cer?from=clinical-trials-and-evidence)[ Clinical & Trials Adaptive Trial Design Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data. ](/terms/adaptive-trial?from=clinical-trials-and-evidence)[ Clinical & Trials Adverse Event(AE) Any untoward medical occurrence in a subject, whether or not related to the device. ](/terms/adverse-event?from=clinical-trials-and-evidence)[ Clinical & Trials Feasibility Study Small clinical study evaluating initial safety, usability, and design parameters of an investigational device. ](/terms/feasibility-study?from=clinical-trials-and-evidence) Cited by Where this term appears across MedTech Terms. Learning paths (2) - [Post-Market Mastery](/paths/post-market-mastery)Lesson 9 of 9 - [Clinical Trials & Evidence](/paths/clinical-trials-and-evidence)Lesson 18 of 18 Ecosystems (2) - [Quality System](/ecosystems/quality-system) - [Clinical Evidence](/ecosystems/clinical-evidence) ## Primary references 3 sources Link health: 3 verified · last checked 2026-06-20 FDA· 1 ICH· 1 ISO· 1 1. [1 FDA RWE Framework Verified FDA · fda.gov ](https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence) 2. [2 ICH Guidelines Verified ICH · ich.org ](https://www.ich.org/page/ich-guidelines) 3. [3 ISO 14155 Standard Page Verified ISO · iso.org ](https://www.iso.org/standard/71690.html) Inline markers like \[1\] jump to the matching reference above. Sponsor note ### Clinical evidence intersecting with device security? We support clinical-stage MedTech teams whose investigational devices touch patient data or hospital networks. [Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session) - No obligation - Expert-led from minute one - NDA available on request MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor. On this term Category Clinical & Trials Acronym RWE Sources 3 Updated 5/5/2026 [Compare with another term](/compare?a=real-world-evidence) Learn in 60 seconds Card Lesson Quiz Clinical evidence regarding the usage and potential benefits or risks of a device derived from real-world data. - · FDA accepts RWE to support regulatory decisions when relevance and reliability are demonstrated. - · RWE is increasingly important for AI/ML monitoring and PMS. Remember this Watch out: RWE derived from unreliable or biased RWD sources may not be accepted by regulatory authorities, leading to delays or rejection of submissions. Related terms - [Post-Market Surveillance(PMS) ](/terms/post-market-surveillance) You may also need Auto-suggested from Clinical & Trials and shared keywords. - [Real-World Data(RWD) ](/terms/rwd) - [RWE for Reimbursement ](/terms/real-world-evidence-reimbursement) - [Investigator Brochure(IB) ](/terms/investigator-brochure) - [Electronic Data Capture(EDC) ](/terms/edc) - [Feasibility Study ](/terms/feasibility-study) - [Informed Consent ](/terms/informed-consent) [All Clinical & Trials terms](/terms?cat=Clinical%20%26%20Trials) From the Blue Goat network Related resources and services on this topic. - [ MedTech Launchpad MedTech funding rounds, accelerators, and launch resources. ](https://medtechlaunchguide.com) MedTech Terms An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices. Browse - [All terms](/terms) - [A–Z index](/a-z) - [Categories](/categories) - [Ecosystems](/ecosystems) - [Learning paths](/paths) - [Compare terms](/compare) - [Quiz](/quiz) Resources - [FDA Medical Devices](https://www.fda.gov/medical-devices) - [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj) - [IMDRF](https://www.imdrf.org/) - [Methodology](/methodology) - [Changelog](/changelog) - [Editor: Christian Espinosa](/authors/christian-espinosa) - [About this site](/about) © 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)